Description
GDC-0973 is a selective inhibitor of MEK1. When used intermittently with the PI3K inhibitor GDC-0941, GDC-0973 shows efficacy in the treatment of Braf and Kras mutant cancer cell lines.
Product Unit Size | Cost | Quantity | Stock |
---|
GDC-0973 is a selective inhibitor of MEK1. When used intermittently with the PI3K inhibitor GDC-0941, GDC-0973 shows efficacy in the treatment of Braf and Kras mutant cancer cell lines.
Cas No. | 934660-93-2 |
---|---|
Purity | ≥99% |
Formula | C21H21F3IN3O2 |
Formula Wt. | 531.32 |
IUPAC Name | {3,4-Difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}{3-hydroxy-3-[(2S)-2-piperidinyl]-1-azetidinyl}methanone |
Synonym | GDC 0973, GDC0973, XL-518, XL 518, XL518, Cobimetinib, RG-7420, RG 7420, RG7420 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Andrlova H., Zeiser R., et al. Cobimetinib (GDC-0973, XL518). Recent Results Cancer Res. 211:177-86 (2018). PMID:30069767.
Hoeflich K., Merchant M., et al. Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition. Cancer Res. 72(1):210-19 (2012). PMID: 22084396.
Cannabinoid receptor 2 selective agonist.
Selective inhibitor of LRRK2.
Polypeptide; peptidoglycan inhibitor.
GABA analog; GABA potentiator, adenosine A1 ago...
Phenylamino pyridine; Abl, c-Kit, PDGFR, PP2A i...
Cysteine derivative, antioxidant, ROS scavenger...
Nav1.8 Na+ channel blocker, potential Nav1.5 Na...
AMPK activator.
Cyclic tetrapeptide; HDAC inhibitor.
Endogenous opioid peptide; μOR agonist.
BRD2/3/4 inhibitor.
p110γ PI3K inhibitor.
Morpholine derivative.
Imidazothiazole; alkaline phosphatase inhibitor...
β1/2-adrenergic antagonist.
Synthetic steroid hormone; AR and ER antagonist...
Naturally occurring amino acid found in grains,...
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Endogenous APP peptide cleavage product, primar...
Synthetic nitrile compound